Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$94.5M |
| 2 |
AGN
Allergan plc
AGN
|
+$62.4M |
| 3 |
WBA
Walgreens Boots Alliance
WBA
|
+$29.7M |
| 4 |
Intercontinental Exchange
ICE
|
+$22.5M |
| 5 |
Boeing
BA
|
+$22.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$69.9M |
| 2 |
Thermo Fisher Scientific
TMO
|
+$67.9M |
| 3 |
Wells Fargo
WFC
|
+$64.1M |
| 4 |
JPMorgan Chase
JPM
|
+$63.1M |
| 5 |
Pfizer
PFE
|
+$62.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.51% |
| 2 | Healthcare | 13.47% |
| 3 | Technology | 13.05% |
| 4 | Industrials | 11.46% |
| 5 | Energy | 9.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AH
2176
DELISTED
Accretive Health
AH
| $1.21M | ﹤0.01% |
132,387
-6,264
| -5% | -$53.9K |
|
|
HSII
2177
DELISTED
Heidrick & Struggles
HSII
| $1.21M | ﹤0.01% |
60,148
+1,152
| +2% | +$21.3K |
|
|
CADX
2178
DELISTED
CADENCE PHARMACEUTICALS, INC COM STK
CADX
| $1.21M | ﹤0.01% |
133,746
+11,292
| +9% | +$81.5K |
|
|
SREV
2179
DELISTED
ServiceSource International, Inc.
SREV
| $1.21M | ﹤0.01% |
144,282
+4,248
| +3% | +$42.7K |
|
2180
Kulicke & Soffa
KLIC
$4.76B
| $1.21M | ﹤0.01% |
90,871
+15,651
| +21% | +$196K |
|
2181
Marten Transport
MRTN
$1.18B
| $1.21M | ﹤0.01% |
149,425
+33,085
| +28% | +$240K |
|
2182
Natural Gas Services Group
NGS
$474M
| $1.21M | ﹤0.01% |
43,773
+1,336
| +3% | +$37.4K |
|
2183
Southside Bancshares
SBSI
$965M
| $1.21M | ﹤0.01% |
52,310
+1,538
| +3% | +$35.3K |
|
|
END
2184
DELISTED
ENDEAVOUR INTERNATIONAL CORP NEW (NV)
END
| $1.2M | ﹤0.01% |
227,983
| – | – |
|
|
AMTG
2185
DELISTED
APOLLO RESIDENTIAL MTG INC COM STK
AMTG
| $1.2M | ﹤0.01% |
80,915
+2,376
| +3% | +$35.5K |
|
|
MITT
2186
TPG Mortgage Investment Trust
MITT
$214M
| $1.2M | ﹤0.01% |
25,468
+1,015
| +4% | +$48.9K |
|
|
AVNR
2187
DELISTED
AVANIR PHARMACEUTICALS, INC CL A
AVNR
| $1.19M | ﹤0.01% |
353,921
-19,290
| -5% | -$79.7K |
|
|
DCOM
2188
DELISTED
Dime Community Bancshares
DCOM
| $1.19M | ﹤0.01% |
70,065
-3,112
| -4% | -$51.6K |
|
|
QGENF
2189
DELISTED
QIAGEN NV
QGENF
| $1.18M | ﹤0.01% |
49,470
+4,070
| +9% | +$96.9K |
|
2190
Banco Santander Chile
BSAC
$16.5B
| $1.18M | ﹤0.01% |
49,831
+945
| +2% | +$22.4K |
|
|
PNNT
2191
Pennant Park Investment Corp
PNNT
$244M
| $1.17M | ﹤0.01% |
101,100
+10,100
| +11% | +$116K |
|
2192
Repligen
RGEN
$9.3B
| $1.17M | ﹤0.01% |
85,900
| – | – |
|
|
ENTR
2193
DELISTED
ENTROPIC COMMUNICATIONS INC COM STK (DE)
ENTR
| $1.17M | ﹤0.01% |
248,461
+50,414
| +25% | +$230K |
|
|
TRNX
2194
DELISTED
TORNIER N V SHARES (NLD)
TRNX
| $1.17M | ﹤0.01% |
62,108
+7,288
| +13% | +$137K |
|
2195
US Physical Therapy
USPH
$1.22B
| $1.17M | ﹤0.01% |
33,075
+4,508
| +16% | +$148K |
|
|
HITK
2196
DELISTED
HI-TECH PHARMACAL INC
HITK
| $1.17M | ﹤0.01% |
26,895
+864
| +3% | +$37.3K |
|
2197
Cavco Industries
CVCO
$4.57B
| $1.17M | ﹤0.01% |
16,955
+504
| +3% | +$30.7K |
|
|
BNCL
2198
DELISTED
Beneficial Bancorp, Inc.
BNCL
| $1.16M | ﹤0.01% |
117,128
+4,425
| +4% | +$41.2K |
|
|
GFIG
2199
DELISTED
GFI GROUP INC
GFIG
| $1.16M | ﹤0.01% |
296,842
-22,544
| -7% | -$81.9K |
|
2200
CDW
CDW
$16.9B
| $1.16M | ﹤0.01% |
49,520
+18,338
| +59% | +$411K |
|
Similar funds
Charles Schwab's Q4 2013 Portfolio in Review
As of Q4 2013, Charles Schwab held 3,132 positions worth $52.5B, up 7% from $49.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Trading was light in Q4 2013: portfolio turnover was 4.1%. Charles Schwab opened 75 new positions and exited 54, leaving the 3,132-position portfolio largely intact.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Technology.
- Charles Schwab's largest Q4 2013 buy was Allergan plc: 398,955 shares worth $67M.
- Charles Schwab added most to Meta Platforms (Facebook) in Q4 2013, an estimated $94.5M increase.
- Charles Schwab's biggest Q4 2013 reduction was Apple, cutting an estimated $69.9M.
- Charles Schwab fully exited DELL INC in Q4 2013, selling an estimated $45.2M.
- Charles Schwab's ten largest holdings make up 14% of its $52.5B portfolio in Q4 2013.
- Charles Schwab opened 75 new positions and closed 54 in Q4 2013.
- Charles Schwab's portfolio value rose 7% quarter-over-quarter to $52.5B.
Based on Charles Schwab's 13F filing for Q4 2013, filed 14 Feb 2014.